ArticleAmerican journal of translational research2023

Durable responses to tislelizumab plus fruquintinib and radiotherapy in refractory microsatellite stable metastatic colorectal cancer: a case report.

Wensi Zhao et al.PubMed ↗Full text ↗

No numbers read from the abstract.